|Videos|August 5, 2016

Isolation Precautions to Prevent HAIs in Healthcare Setting

Matt Linam, MD, MS, medical director of Infection Prevention at Arkansas Children’s Hospital, discusses the importance of isolation precautions to prevent healthcare associated infections.

Matt Linam, MD, MS, medical director of Infection Prevention at Arkansas Children’s Hospital, discusses the importance of isolation precautions to prevent healthcare associated infections.

Interview Transcript (slightly modified for readability).

“[Un]fortunately there’s not a lot of evidence that relates to parents and visitors using isolation precautions and its positive impact on preventing infections. Having said that, we know that parents and visitors spend quite some time in a patient’s room and it can potentially become contaminated while they’re in there and take those organisms out into the healthcare environment.

One positive thing is, most of the time, parents and visitors are only visiting one patient so they’re not necessarily transmitting from room to room to room like we see with healthcare workers. But, hand hygiene and use of isolation precautions, [have] been shown in multiple studies to be beneficial for healthcare workers and preventing healthcare associated infections, so it makes good sense.”


Related to this article

The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.